Podcasts about ucl institute

Ask Claude a question, Google a query, order from Amazon, chat with mates on WhatsApp, tune in to Youtube. And where ever you do it from, you'll never be somehow not in America. Because Britain, like Europe is dependent on US tech and as the AI revolution unfolds, governments are increasingly worried about it. The new buzz phrase is digital sovereignty. But what does that mean? Is it even feasible? And can the UK and the Europe take back control? David Aaronovitch talks to:Stanley Pignal, Europe editor at The Economist Cecilia Rikap, Associate Professor in Economics and Head of Research at the UCL Institute for Innovation and Public Purpose Seb Johnson, founder of Scaling Europe, a media company focused on European TechPresenter: David Aaronovitch Producers: Ben Carter, Sally Abrahams, Kirsteen Knight Production Co-ordinator: Gemma Ashman Sound engineer: James Beard Editor: Richard Vadon

Hans Svennevig joins Dr Hakan Ergül to explore the ethical challenges that emerge as researchers use AI tools and wearable technologies.Hakan and Hans discuss how these systems complicate consent, privacy, autonomy, and the researcher–participant relationship. They ask whether existing ethical principles are robust enough for technologies that collect and interpret data continuously, often without active awareness.Their conversation draws on the AI and Technology Wearables Task and Finish Group Report and Recommendations (2025), commissioned by the UCL Institute of Education Research Ethics Committee and chaired by Hans.Full show notes and links: https://www.ucl.ac.uk/ioe/news/2026/apr/ai-tech-wearables-and-ethics-research-ethicsMore IOE Insights podcasts: https://uclioe.info/podcastUCL Institute of Education: https://ucl.ac.uk/ioe

Is political power built on institutions or on the stories we choose to believe?What is Islamism, and how do political narratives shape power in the Muslim world?In this episode of Thinking Islam, Dr Fatemeh Sadeghi explores Islamism, political narratives, and how storytelling shapes political power and legitimacy. Drawing on both Islamic intellectual traditions and modern social theory, Dr Sadeghi examines how narratives do more than describe reality - they actively shape it. From early Islamic history, where hadith and sīra were used to legitimise authority, to contemporary movements such as Islamism and the far right, we uncover how political stories mobilise people through promises of justice, salvation, and belonging. We also examine the decline of Islamism as a compelling narrative, and the “melancholic condition” it has left behind in many Muslim societies—a space marked by disillusionment, yet still open to new possibilities. The conversation raises a profound question: if all political and even religious commitments are mediated through stories, what kinds of narratives are needed today to sustain hope, dignity, and meaningful collective life?Dr Fatemeh Sadeghi is a sociologist and political theorist at the UCL Institute for Global Prosperity. Her research explores political imagination, gender, and the role of narrative in shaping social order and legitimacy, offering a powerful lens for understanding the moral and political crises of our time.Audio Chapters:00:00 - Highlights01:20 - What is a Narrative?03:05 - Political Narrative: Stories That Shape Power06:39 - Two Kinds of Narratives13:19 - Good vs Evil: ‘Us and Them'17:17 - Isn't the Quran doing the same thing?23:00 - Nostalgia as a Response to Colonialism30:00 - Can some Narratives Cause more ‘Legitimacy'?36:10 - Living Through a ‘Melancholic' Moment40:25 - Islamism Moved from Theology to Power43:24 - What Comes After Islamism as a New Narrative?48:30 - Who Creates Narratives when Knowledge is Democratised?56:30 - New ‘Islam' narratives are still grounded in Morality01:00:50 - Thinking Islam Question

Dr. Peter Moss is an Emeritus Professor at the Thomas Coram Research Unit, UCL Institute of Education, University College London. His research and writing interests cover early childhood education, education and democracy, and the relationship between employment, care and gender. Much of his work has been cross-national, especially covering Europe and the Anglosphere. He is co-founder of the International Network on Leave Policies and (with Gunilla Dahlberg) was the initial editor for the Contesting Early Childhood book series. He has published widely, his most recent books being Early Childhood in the Anglosphere: Systemic failings and transformative possibilities (with Linda Mitchell; 2024, UCL Press) and Care Leaves and Care Time for All: Towards caring democracies, economies and worlds (with Andrea Doucet; April 2026, Policy Press).

This conversation traces Professor Li Wei's path from classroom teacher to Director and Dean of the UCL Institute of Education, showing how lived experience drove his research questions. He explains language shift in three generations and why some children become English‑dominant despite living in multilingual homes. With deep expertise in bilingualism and multilingual education, he shares evidence‑based ways to support heritage language maintenance. There's practical insights for educators, families, and early career researchers alike.More about Professor Li Wei and related links: https://uclioe.info/4sHzlJrMore IOE Insights podcasts: https://uclioe.info/podcastUCL Institute of Education: https://ucl.ac.uk/ioe

On this episode of Mind the Gap, Tom Sherrington and Emma Turner are joined by Professor Becky Francis, CEO of the Education Endowment Foundation, for a rich and wide-ranging discussion about the role of evidence in improving education - and the complexities that come with it. Becky unpacks how the EEF has evolved from a research-focused organisation into a trusted, sector-facing resource used by the vast majority of schools. The conversation explores the power - and limits - of randomised controlled trials, the importance of meta-analysis and implementation, and why teaching can be considered a “best bets” profession shaped by context and professional judgement. Along the way, they tackle big questions around social justice, student grouping and attainment, the risks of initiative overload, and how teachers can engage meaningfully with evidence without oversimplifying it. Looking ahead, Becky highlights key frontiers for research: AI, SEND, and school improvement at scale - making this an insightful and thought-provoking episode for anyone interested in how evidence can genuinely inform practice without losing sight of the realities of the classroom.Professor Becky Francis CBE is currently CEO of the Education Endowment Foundation, and was previously Director of the UCL Institute of Education (IOE), which is ranked #1 in the world for education in the international QS rankings. Her prior roles include Professor of Education and Social Justice at King's College London, Director of Education at the RSA and Standing Advisor to the Parliamentary Education Select Committee. Throughout her career, Becky has sought to maximise the impact of academic research by working closely with teachers and policy-makers. She has spearheaded high-profile research programmes assessing the impact of major reforms in the English school system on educational inequalities, and is sought out internationally as an advisor to Governments on education policy. Becky was the inaugural Charles Yidan Global Fellow at Harvard University. Her academic expertise and extensive publications centre on social identities and inequalities in educational contexts. She is best known for her body of research on social identities and educational attainment, including gender, race and social class.Tom Sherrington has worked in schools as a teacher and leader for 30 years and is now a consultant specialising in teacher development and curriculum & assessment planning. He regularly contributes to conferences and CPD sessions locally and nationally and is busy working in schools and colleges across the UK and around the world. Follow Tom on X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@teacherhead⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Emma Turner FCCT is a school improvement advisor, education consultant, trainer and author. She has almost three decades of primary teaching, headship and leadership experience across the sector, working and leading in both MATs and LAs. She works nationally and internationally on school improvement including at single school level and at scale. She has a particular interest in research informed practice in the primary phase, early career development, and CPD design. Follow Emma on X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@emma_turner75⁠⁠⁠⁠⁠⁠⁠⁠⁠This podcast is sponsored by Teaching WalkThrus and produced in association with Haringey Education Partnership. Find out more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://walkthrus.co.uk/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://haringeyeducationpartnership.co.uk/⁠

What does a PhD journey look like when you paint it rather than write it?Louise and Tooba are two international doctoral students at the UCL Institute of Education, and in 2026 they are navigating the third year of their PhD programmes. Each month they will meet to sit down, talk, and paint. These sessions turn reflective conversations into visual stories, using art to bring their PhD experience to life on the page - their 'PhD Sketchbook'.In this episode they explore the beginnings of their journeys: the “seeds” that motivated them to start a PhD, their paths to London, and the small moments that help an unfamiliar city slowly feel like home, all shared over canvas and colour.You can see the artworks they created during this episode on the UCL IOE student blog, and on the IOE Instagram account.Full show notes and links: https://www.ucl.ac.uk/ioe/news/2026/mar/painting-our-way-through-research-belonging-and-london-phd-sketchbook 

Em fevereiro de 2026, o European Schoolnet publicou um relatório que vai direto ao coração de uma das questões mais prementes da educação contemporânea: como avaliar o que os professores aprendem, quando a própria inteligência artificial (IA) está a transformar aquilo que precisam de saber — e as ferramentas com que aprendem?​ O documento — Assessing Teacher Learning in the Age of AI — resulta do 6.º Seminário Temático da European Schoolnet Academy e foi elaborado por investigadores da UCL Institute of Education e da equipa pedagógica do European Schoolnet. As suas conclusões são simultaneamente um diagnóstico e um guia de ação para educadores, formadores e decisores políticos.​

Em fevereiro de 2026, o European Schoolnet publicou um relatório que vai direto ao coração de uma das questões mais prementes da educação contemporânea: como avaliar o que os professores aprendem, quando a própria inteligência artificial (IA) está a transformar aquilo que precisam de saber — e as ferramentas com que aprendem?​O documento — Assessing Teacher Learning in the Age of AI — resulta do 6.º Seminário Temático da European Schoolnet Academy e foi elaborado por investigadores da UCL Institute of Education e da equipa pedagógica do European Schoolnet. As suas conclusões são simultaneamente um diagnóstico e um guia de ação para educadores, formadores e decisores políticos.​

Yanis Varoufakis and Raphael Arar discuss the Monetary Commons. Find the feed of English episodes only here: https://www.futurehistories-international.com/ You can also import the RSS feed to your favorite app: https://www.futurehistories-international.com/feed.xml   Shownotes Yanis' website: https://www.yanisvaroufakis.eu/ Raphael's website: https://rarar.com/ Iza Romanowska at Aarhus University: https://pure.au.dk/portal/en/persons/iza-romanowska/ Hirad's website: https://hiradsab.com/ the Monetary Commons website: https://monetarycommons.com/ Varoufakis, Y. (2024). Technofeudalism. What Killed Capitalism. Vintage Books. https://www.penguin.co.uk/books/451795/technofeudalism-by-varoufakis-yanis/9781529926095 Varoufakis, Y. (2021). Another Now. Melville House. https://www.mhpbooks.com/books/another-now/ on the 2025 German ‘Sondervermögen'/‘The Special Fund for Infrastructure and Climate Neutrality': https://www.bundesfinanzministerium.de/Web/EN/Issues/Public-Finances/SVIK/special-fund-infrastructure-and-climate-neutrality.html on Wolfgang Schäuble: https://en.wikipedia.org/wiki/Wolfgang_Sch%C3%A4uble Graeber, D. (2011). Debt. The first 5,000 Years. Melville House. https://files.libcom.org/files/__Debt__The_First_5_000_Years.pdf on IOU's: https://en.wikipedia.org/wiki/IOU on the Money Market Multiplier: https://en.wikipedia.org/wiki/Money_multiplier on Ludwig Wittgenstein's argument of the impossibility of a private language: https://plato.stanford.edu/entries/private-language/ on the Digital Renminbi in China: https://en.wikipedia.org/wiki/Digital_renminbi on Universal Basic Income (UBI): https://en.wikipedia.org/wiki/Universal_basic_income Berry, C. (2023). The Case for a Universal Basic Dividend. UCL Institute for Innovation and Public Purpose, Policy Brief series 25. https://www.ucl.ac.uk/bartlett/sites/bartlett/files/berry_c_2023._the_case_for_a_universal_basic_dividend.pdf on fiat money: https://en.wikipedia.org/wiki/Fiat_money Varoufakis, Y. (2013). Bitcoin and the Dangerous Fantasy of ‘Apolitical' Money. https://www.yanisvaroufakis.eu/2013/04/22/bitcoin-and-the-dangerous-fantasy-of-apolitical-money/ on the case of Nicolas Guillou, French ICC judge, being sanctioned by the US: https://www.lemonde.fr/en/international/article/2025/11/19/nicolas-guillou-french-icc-judge-sanctioned-by-the-us-you-are-effectively-blacklisted-by-much-of-the-world-s-banking-system_6747628_4.html on the distributed ledger technology: https://en.wikipedia.org/wiki/Distributed_ledger Mau, S. (2023). Mute Compulsion. A Marxist Theory of the Economic Power of Capital. Verso. https://www.versobooks.com/products/2759-mute-compulsion McCarthy, M. A. (2025). The Master's Tools. How Finance Wrecked Democracy (And a Radical Plan to Rebuild It). Verso. https://www.versobooks.com/products/755-the-master-s-tools Sorg, C. (2025). Finance as a Form of Economic Planning. Competition & Change, 29(1), 17-37. https://journals.sagepub.com/doi/10.1177/10245294231217578 on citizen's assemblies: https://en.wikipedia.org/wiki/Citizens%27_assembly on the International Monetary Fund (IMF): https://en.wikipedia.org/wiki/International_Monetary_Fund on the Digital Euro: https://www.ecb.europa.eu/euro/digital_euro/html/index.en.html the essay that includes the quote by Peter Thiel on the incompatibility of liberalism/capitalism and democracy: https://www.cato-unbound.org/2009/04/13/peter-thiel/education-libertarian/ on the Meidner Plan: https://jacobin.com/2025/08/sweden-socialism-rehn-meidner-plan on the Trump administration buying 10% of Intel shares: https://www.pbs.org/newshour/politics/what-economic-and-policy-experts-think-about-the-u-s-governments-stake-in-intel on Cloud Capital (see also Yanis' ‘Technofeudalism' book): https://youtu.be/3gsGvgrsyOU?si=fQwW5BEHBFDvB980 on Ursula K. Le Guin: https://de.wikipedia.org/wiki/Ursula_K._Le_Guin the speech including the mentioned quote by her: https://youtu.be/Et9Nf-rsALk?si=VCGW4OoDqY0HXa2E on the 1973 Coup in Chile: https://en.wikipedia.org/wiki/1973_Chilean_coup_d%27%C3%A9tat on Modern Monetary Theory (MMT): https://de.wikipedia.org/wiki/Modern_Monetary_Theory on Fernando Haddad: https://en.wikipedia.org/wiki/Fernando_Haddad on pix: https://en.wikipedia.org/wiki/Pix_(payment_system) on the 2008 financial crisis in Iceland: https://en.wikipedia.org/wiki/2008%E2%80%932011_Icelandic_financial_crisis Future Histories Episodes on Related Topics S3E29 | Nancy Fraser on Alternatives to Capitalism https://www.futurehistories.today/episoden-blog/s03/e29-nancy-fraser-on-alternatives-to-capitalism/ S03E21 | Christoph Sorg zu Finanzwirtschaft als Planung https://www.futurehistories.today/episoden-blog/s03/e21-christoph-sorg-zu-finanzwirtschaft-als-planung/ S03E19 | Wendy Brown on Socialist Governmentality https://www.futurehistories.today/episoden-blog/s03/e19-wendy-brown-on-socialist-governmentality/ S02E34 | tante zu Crypto-Imaginaries und alternativen technologischen Infrastrukturen https://www.futurehistories.today/episoden-blog/s02/e34-tante-zu-crypto-imaginaries-und-alternativen-technologischen-infrastrukturen/ S02E28 | Marcus Meindel zum Global Commoning System https://www.futurehistories.today/episoden-blog/s02/e28-marcus-meindel-zum-global-commoning-system/ S01E59 | Joscha Wullweber zu Zentralbankkapitalismus https://www.futurehistories.today/episoden-blog/s01/e59-joscha-wullweber-zu-zentralbankkapitalismus/ S01E34 | Aaron Sahr zu monetärer Souveränität und Modern Monetary Theory (Teil 2) https://www.futurehistories.today/episoden-blog/s01/e34-aaron-sahr-zu-monetaerer-souveraenitaet-und-modern-monetary-theory-teil-2/ S01E33 | Aaron Sahr zu monetärer Souveränität und Modern Monetary Theory (Teil 1) https://www.futurehistories.today/episoden-blog/s01/e33-aaron-sahr-zu-monetaerer-souveraenitaet-und-modern-monetary-theory-teil-1/    Future Histories Contact & Support If you like Future Histories, please consider supporting us on Patreon: https://www.patreon.com/join/FutureHistories Contact: office@futurehistories.today Twitter: https://twitter.com/FutureHpodcast Instagram: https://www.instagram.com/futurehpodcast/ Mastodon: https://mstdn.social/@FutureHistories English webpage: https://futurehistories-international.com   Episode Keywords #YanisVaroufakis, #RaphaelArar #JanGroos, #Interview, #FutureHistories, #FutureHistoriesInternational, #futurehistoriesinternational, #MonetaryCommons, #Commons, #Transition, #Capitalism, #Socialism, #Narratives, #MMT, #CentralBanks, #MoneyCreation, #Commoning, #Finance

Send us a textDr. Carina Kern, Ph.D. is the CEO of LinkGevity ( https://www.linkgevity.com/ ),  an AI-powered biotech company driving innovation in drug discovery for aging and resilience loss. Dr. Kern has developed a new Blueprint Theory of Aging, which takes an integrative approach to understanding aging, combining evolutionary theory, genetics, molecular mechanisms and medicine, and is used to structure LinkGevity's AI. Dr. Kern's labs are based at the Babraham Research Campus, affiliated with the University of Cambridge and her research has led to the development of a first-in-class necrosis inhibitor targeting cellular degeneration (Anti-Necrotic™). This novel therapeutic is ready to begin Phase II clinical trials later this year, as a potential breakthrough treatment for aging, with UK Government, Francis Crick Institute KQ labs, and European Union (Horizon) support. The Anti-Necrotic™ has also been selected as one of only 12 global innovations for NASA's Space-Health program, recognizing its potential to mitigate accelerated aging in astronauts on long-duration space missions. Dr. Kern has held academic and leadership roles in interdisciplinary networks, including serving as President of the London Evolutionary Research Network and Co-Chair of the CleanTech Business Challenge, an initiative co-led by University College London and the London Business School.Dr. Kern completed her PhD at UCL Institute of Healthy Ageing.#CarinaKern #LinkGevity #BlueprintTheoryOfAging #BiologicalResilience #UniversityOfCambridge #BabrahamResearchCampus #CellularDegeneration #NecrosisInhibitor #AntiNecrotic #CaenorhabditisElegans #UCLInstituteOfHealthyAgeing #Senescence #Apoptosis #CellDeath #Necroptosis #Pyroptosis #Ferroptosis #PathoPathways #Gerotherapeutics #RyanodineReceptorInhibitors #CellPermeantCalciumChelators #LINK001 #AcuteKidneyInjury #SpaceMedicine #Exposome #Longevity#ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textThis week on the Less Stressed Life, we're talking vision, mitochondria, and light with ophthalmologist and UCL researcher Glen Jeffery. We explore why the retina is so energy hungry and how simple exposure to long wavelength light and even plain incandescent lighting can measurably support aging eyes.We dig into wavelength and dose, why morning timing matters most, what makes incandescent bulbs uniquely powerful, and practical ways to protect your eyes from modern indoor lighting.If you've ever battled screen related eye strain, worried about declining vision, or felt lost in the red light maze, this conversation brings clarity and simple next steps.KEY TAKEAWAYS: • Morning light best activates mitochondria and supports eye health • Just three minutes of red or long wavelength light can boost color vision • Benefits fade after about five days without continued exposure • Incandescent bulbs outperform LEDs for vision and energy support • Blue light and LEDs can drain mitochondrial function • Avoid lasers; low intensity LEDs or sunlight are safest • Daily natural light is the simplest, most effective therapyABOUT GUEST:Dr. Glen Jeffery is a Professor of Neuroscience at the UCL Institute of Ophthalmology. His research focuses on how aging and light exposure affect the retina and mitochondrial function. He has pioneered studies showing how specific wavelengths of light, including red and infrared, can improve visual performance and support healthy aging of the eye. His work bridges neuroscience, ophthalmology, and environmental health, emphasizing practical, light-based approaches to protect and restore vision. WHERE TO FIND: Email:  g.jeffery@ucl.ac.ukWHERE TO FIND CHRISTA:Website: https://www.christabiegler.com/Instagram: @anti.inflammatory.nutritionistPodcast Instagram: @lessstressedlifeYouTube: https://www.youtube.com/@lessstressedlifeNUTRITION PHILOSOPHY OF LESS STRESSED LIFE:

Arthur Kay is an entrepreneur, and advisor to organisations building solutions for sustainable cities.He is the founder of several urban design and technology companies, including the clean technology company – Bio-bean (acq. 2023), the design, technology, and development company – Skyroom, and the £100m Key Worker Homes Fund.Arthur is an advisor to organisations including Innovo Group, and serving as a board member for Transport for London, The Royal Academy of Engineering, the Museum of the Home, and Fast Forward 2030.In addition, Arthur holds academic appointments, as Associate Professor (Hon.) at UCL Institute for Global Prosperity. He has lectured on urban design at MIT, NYU, LSE and Imperial College London. He is co-author of the book Roadkill: Unveiling the True Cost of Our Toxic Relationship with Cars (Wiley, 2025), with Professor Dame Henrietta Moore.Arthur's work building solutions for sustainable cities has been recognised by the UN as a Sustainable Development Goals Pioneer, The Guardian as Sustainable Business Leader of the Year, MIT Technology Review as a 35-under-35 and Forbes as an all-star 30-under-30. His words and work have appeared in publications, including The Times, The Financial Times, The New York Times,  Bloomberg, National Geographic, The New Scientist, The Wall Street Journal, The Telegraph, The Guardian, The Washington Post, Al Jazeera, CNN, CNBC, CBS, Wired, Architect's Journal, Architectural Review, and on the BBC.Arthur studied architecture at UCL Bartlett School of Architecture, and entrepreneurship at Stanford's Graduate School of Business.

Episode title: Ageing Playfully: Transforming perspectives on growing older In this episode of Public Health Disrupted, host Rochelle Burgess is flying solo, and dives into the transformative power of play in the context of ageing. Joined by Rachel Colles, a professional performer and ‘Elderflower' with Hearts and Minds, and Dr Carrie Ryan, a lecturer in Creative Health at UCL, the discussion explores how playfulness can disrupt conventional narratives surrounding ageing. Rochelle, Rachel, and Carrie challenge the societal tendency to associate play solely with childhood, revealing how embracing play in later life can foster joy, creativity, and meaningful connections. They share insights from their experiences, including engaging with people living with dementia and the profound impact of playful interactions (and bingo!) in care settings. The conversation highlights the importance of validating emotions, and how play serves as a vital public health intervention, encouraging a shift in perspective on ageing. This episode also touches on the significance of fostering genuine connections, ultimately advocating for a more playful approach to public health. Featured in this episode: Host: Rochelle Burgess – Community Health Psychologist and Professor at the UCL Institute for Global Health Guests: Rachel Colles– Professional Performer and Elderflower, Hearts and Minds Dr Carrie Ryan – Lecturer in Creative Health, UCL Department of Arts and Sciences Resources and mentions: ‘Extravagant Acts for Mature People' by Phoebe Davies (as mentioned at the end of this episode by Dr Carrie Ryan!) Date of episode recording: 2025-07-23 Duration: 00:42:57 Language of episode: English Producer: Produced by UCL Health of the Public and edited by Annabelle Buckland, Decibelle Creative Link to transcript: https://www.ucl.ac.uk/health-of-public/news-and-events/public-health-disrupted/season-5-ep-5-ageing-playfully-notes-and-transcript

Today's tighter fiscal position around the world is pushing governments to find alternatives to finance their current expenditure and public investments, forcing them to think differently about how they fund and deliver essential services. Dean Yates, regional market segment leader in government and health sciences, Oceania, at EY, and Rainer Kattel, deputy director and professor of innovation and public governance at the UCL Institute for Innovation and Public Purpose, join Andrea Correa, senior economist at OMFIF, to explore what it takes to make public investment work. They discuss the government's position and trade-offs around public investment, how to prioritise and measure investments for long-term impact and the role of innovation and governance in delivering value across health, education and infrastructure.

An NHS vaccine for chickenpox will be rolled out in England from January, in the biggest expansion of the childhood immunisation programme for a decade. It will be offered as part of a new combined MMRV vaccine, for measles, mumps, rubella and varicella, by GPs. Professor Helen Bedford, from the UCL Institute of Child Health joins us with the latest.And in part two, The Standard's Culture Writer India Block joins us to discuss pop star Sabrina Carpenter's new album, Man's Best Friend. Hosted on Acast. See acast.com/privacy for more information.

Sussex-born cellist Laura van der Heijden won the BBC Young Musician of the Year at the age of 15 in 2012. She's now been named as the Royal Philharmonic Society's Instrumentalist of the Year and will be the Artist in Residence at this year's Lammermuir Festival in Scotland. Laura tells Kylie Pentelow about her repertoire, her love of the outdoors, and plays live in the studio.Women who've been stalked, or had to take out a restraining order, have a much higher chance of suffering a heart attack or stroke, according to a new study from Harvard T.H. Chan School of Public Health. It followed a group of over 66,000 women across 10 years, and found those who'd been stalked were 41% more likely to develop cardiovascular disease, with those who'd taken out a restraining orders 71% more likely to have heart problems. Kylie talks to Dr Audrey Murchland, one of the lead researchers who carried out the study, about their findings.Paula Byrne, Jane Austen's biographer and also a novelist, has spent 25 years researching and writing about the iconic author. In this 250th anniversary year of Austen's birth, she joins Kylie to talk about her new novel, Six Weeks by the Sea, which is her first fictional treatment of Austen and tells the story of how she imagines the most famous romance writer of all time first fell in love.New government guidance on sex education coming in next year doesn't include specific information on how children should be taught about menstruation, despite a new study showing children don't get enough lessons on the subject. Researchers from University College London claim children get at most two sessions on periods and they say boys and girls should be taught about it together. The study was led by Professor Joyce Harper from the UCL Institute for Women's Health. She joins Kylie along with Tina Leslie from the charity Freedom for Girls, which provides period education.Presenter: Kylie Pentelow Producer: Andrea Kidd

The creation of a landmark gene editing drug used to treat a baby with a rare genetic mutation which could help transform personalized medicine. Blood tests showed baby KJ had sky-high levels of ammonia, a toxic substance the body usually expels. The root cause was his genes - or more particularly a specific gene mutation. The race was on to try and treat him before his condition took a firm hold. His doctors came up with a radical solution - for the first time ever, they designed and applied a gene-editing drug in record time, specifically for him. Have we seen breakthrough in preventing genetic diseases? With Fyodor Urnov, a professor in the Molecular and Cell Biology Department at the University of California, Virginijus Šikšnys professor at the Life Science Center of Vilnius University, Waseem Qasim from the UCL Institute of Child Health in Great Ormond Street Hospital in London and Jennifer Doudna, Professor, University of California, Berkeley and founder of the Innovative Genomics Institute. Presented by Tanya Beckett. Produced by Bob Howard. Researched by Mauve Schaffer Edited by Tara McDermott.

Last week, President Trump signed a memorandum calling for reciprocal tariffs on countries that charge fees on US exports and called his 25% tariff order on all steel and aluminum imports “the beginning of making America rich again.” But is it? We turn to three brilliant economists for their takes (and disagreements) on the real impact Trumponomics will have on the U.S. economy. Kara leads a spirited and insightful conversation about industrial policy, the efficacy of Trump's tariffs, how worried we should really be about the U.S. 's trade deficit, the odds of an AI bubble and bail out, and, of course, DOGE. Featuring:  Oren Cass, the founder and chief economist of American Compass, a conservative think tank, and a contributing opinion writer for the Financial Times and the New York Times.  Paul Krugman, a Nobel Prize-winning economist who writes a newsletter on Substack, teaches at the City University of New York Graduate Center, and recently retired his New York Times Opinion column after writing it from 2000 to 2025. And Mariana Mazzucato, a professor of economics at University College London, where she is Founding Director of the UCL Institute for Innovation & Public Purpose and author of the hugely influential book, The Entrepreneurial State. This episode was recorded on Monday, February 10. Questions? Comments? Email us at on@voxmedia.com or find us on Instagram and TikTok @onwithkaraswisher Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, our guests explore the impact of genetic discoveries on inherited retinal dystrophies, in particular retinitis pigmentosa (RP). The discussion highlights a recent study that identified two non-coding genetic variants linked to RP, predominantly in individuals of South Asian and African ancestry. The conversation highlights how advances in whole genome sequencing are uncovering previously hidden causes of genetic disease, improving diagnostic rates, and shaping the future of patient care. It also addresses the challenges faced by individuals from diverse backgrounds in accessing genetic testing, including cultural barriers, awareness gaps, and historical underrepresentation in genomic research. Our host Naimah Callachand is joined by researcher Dr Gavin Arno, Associate Director for Research at Greenwood Genetic Centre in South Carolina, Kate Arkell, Research Development Manager at Retina UK, and Bhavini Makwana, a patient representative diagnosed with retinitis pigmentosa and Founder and Chair of BAME Vision. We also hear from Martin Hills, an individual diagnosed with autosomal dominant retinitis pigmentosa. To access resources mentioned in this episode: Access the Unlock Genetics resource on the Retina UK website Visit the BAME vision website for more information and support Find out more about the groundbreaking discovery of the RNU4-2 genetic variant in the non-coding region which has been linked to neurodevelopmental conditions in our podcast episode   "Discoveries like this lead to better clinical management. We understand better the progression of the disease when we can study this in many individuals from a wide spectrum of ages and different backgrounds. We can provide counselling as Bhavini was talking about. We can provide patients with a better idea of what the future may hold for their eye disease, and potentially, you know, we are all aiming towards being able to develop therapies for particular genes and particular diseases."   You can download the transcript or read it below. Naimah: Welcome to Behind the Genes.   Bhavini: The few common themes that always come out is that people don't really understand what genetic testing and counselling is. They hear the word counselling, and they think it is the therapy that you receive counselling for your mental health or wellbeing. There is already a taboo around the terminology. Then it is lack of understanding and awareness or where to get that information from, and also sometimes in different cultures, if you have been diagnosed with sight loss, you know blindness is one of the worst sensory things that people can be diagnosed with. So, they try and hide it. They try and keep that individual at home because they think they are going to have an outcast in the community, in the wider family, and it would be frowned upon).  Naimah: My name is Naimah Callachand and I am Head of Product Engagement and Growth at Genomics England.  I am also one of the hosts of Behind the Genes. On today's episode I am joined by Gavin Arno, Associate Director for Research at Greenwood Genetic Centre in South Carolina, Kate Arkell, Research Development Manager at Retina UK, and Bhavini Makwana, patient representative.  Today we will be discussing findings from a recently published study in the American Society of Human Genetics Journal which identified two non-coding variants as a cause of retinal dystrophy in people commonly of South Asian and African ancestry. If you enjoy today's episode, we'd love your support. Please like, share, and rate us on wherever you listen to your podcasts.  Okay, so first of all I would like to ask each of the three of you to introduce yourselves. Bhavini, maybe we'll start with you.  Bhavini: Hi, I'm Bhavini Makwana, patient representative, and also Chair of BAME Vision. I have other roles where I volunteer for Retina UK, and I work for Thomas Pocklington Trust.  Naimah: Thanks Bhavini. Gavin.  Gavin: Hi, my name is Gavin Arno, I am Associate Director for Research at the Greenwood Genetic Centre in South Carolina, and I am Honorary Associate Professor at the UCL Institute of Ophthalmology in London.  Naimah: Thanks Gavin. And Kate.   Kate: Hi, I'm Kate Arkell, Research Development Manager at Retina UK.   Naimah: Lovely to have you all today. So, let's get into the conversation then. So Gavin, let's come to you first. First of all, what is retinitis pigmentosa and what does it mean to have an inherited retinal dystrophy?  Gavin: So, retinitis pigmentosa is a disorder that affects the retina at the back of the eye. It is a disease that starts in the rod photoreceptor cells. So, these cells are dysfunctional and then degenerate causing loss of peripheral and night vision initially, and that progresses to include central vision and often patients will go completely blind with this disease. So, retinal dystrophies are diseases that affect the retina. There are over 300 genes known to cause retail dystrophy so far, and these affect different cells at the back of the eye, like retinitis pigmentosa that affects the rods. There are cone rod dystrophies, ones that start in the cone photoreceptors, macular dystrophies that start in the central retina, and other types of retinal dystrophies as well.  Naimah: Thanks Gavin. And Bhavini, just to come next to you. So, you received a diagnosis of retinitis pigmentosa at the age of 17 after a genetic change was found in the RP26 CERKL gene. At this time only ten other families in the UK had been identified with this type of genetic alteration. Would you mind sharing a bit more about your journey to your diagnosis?  Bhavini: Yeah. So, at the age of 17 is when I got officially diagnosed with retinitis pigmentosa, but leading up to that I was experiencing symptoms such as night blindness. So, I struggled really badly to see in the dark, or just in dim lighting, like this time of the year in winter when it gets dark quite easily, all my friends from college could easily walk across the pavement, but I struggled. I was bumping into a lot of things. Like things that I wouldn't really see now that I know my peripheral vision, I was losing that, so like lamp posts or trees or bollards, I would completely miss or bump into them. I was missing steps, and had a really, really bad gaze to the sun. Like, everything was really hazy. That continued and I just put it down to stress of exams. You know, just given that age and where I was at the time of my life. But then it kind of continued. So, I went to the see the optician who then referred me, and after months of testing I got diagnosed with retinitis pigmentosa. Back in the late 90s when I was diagnosed there wasn't really anything about genetic testing, or cures., or treatments. I was basically just told to get on with it, and that was it.   It was only until about 15/16 years later I came across Retina UK, started understanding what retinitis pigmentosa is, and what it means, and then when I was offered genetic testing and counselling at one of my annual Moorfields appointments, they explained to me what it involved, what it could mean, what kind of answers I would get, and I agreed to take part. It was a simple blood test that myself and both my parents took part in.      Naimah: Thanks for sharing that Bhavini. So, I know you were able to receive a diagnosis through whole genome sequencing in the 100,000 Genomes Project after the alteration in the gene was found, and this was found in the coding region of the genome. But in this study that we are talking about in this podcast, we know that the two genetic changes that were found, they were in the non-coding region of the genome. Gavin, could you tell me in simple terms what the difference is between the coding and non-coding region of the genomes and why these findings are significant in this case?   Gavin: Yes, sure. So, the human genome is made up of about 3 billion letters or nucleotides which are the instructions for life essentially. Now, within that human genome there are the instructions for roughly 20,000-25,000 proteins. This is what we call the coding genome. These are the bits of DNA that directly give the instructions to make a protein. Now, we know that that part of the genome is only roughly 2% of the entire genome, and the remaining 98% is called the non-coding genome. Now, we understand that far less well. We have a far poorer understanding of what the function of the non-coding genome is versus the coding genome. So, typically molecular diagnostic testing or genetic testing is focused on the coding genome, and historically that has been the fact. Now with advances in genome technologies like whole genome sequencing and the 100,000 Genomes Project, we are able to start to look at the non-coding genome and tease out the previously poorly understood causes of genetic diseases that may lie within those regions of the genes.   Naimah: Thanks Gavin, I think you have just really highlighted the possibilities available with looking at the non-coding region of the genome.  Kate, coming to you next. I wanted to talk about the importance of uncovering and understanding genetic causes of inherited retinal dystrophies, and how do discoveries like these change the landscape of care for patients with inherited retinal dystrophies?  Kate: So, getting a genetic diagnosis can really help families affected by inherited retinal dystrophy. It helps them and their ophthalmologists to better understand their condition, and in some cases gain some insight into possible prognosis, which helps people feel a lot more in control. It can also potentially inform family planning decisions and even open up options around access to reproductive technologies for example, not only for the individual, but sometimes also for their close relatives. Of course, researchers are making great strides towards therapies, some of which have reached clinical trials. But a lot of these approaches are gene specific, so for people who know their genetic diagnosis, they are more able to recognise research that is most relevant to them and quickly pick out potential opportunities to take part. At the moment it is still the case that around 30% of our community who have a genetic test will not receive a clear result, and that can feel very frustrating. So, the more discoveries like this that are made, the better.   Naimah: Thanks Kate.  So, now we are going to hear a clip from Martin Hills, our Retina UK patient representative who has been diagnosed with autosomal dominant retinitis pigmentosa. Martin has undergone genetic testing and shares more about his experience.  Martin: My name is Martin Hills, and I was officially diagnosed with autosomal dominant retinitis pigmentosa in 2001, and because of that I immediately had to stop driving which made a huge impact both on myself and my family.  My eyesight has slowly deteriorated over the years. It first started with difficulty seeing at night, and also playing some types of sport, which I think probably was in my 20s. My peripheral vision has been lost slowly and now has completely gone. Fortunately, I still have some reasonable central vision left which is a great help. I am registered as severely sight impaired, and I am also a symbol cane user. My father and aunt were both diagnosed with this condition, and my daughter has been relatively recently, as has altogether eight members of our wider family, and that also includes two younger generations. In 2015 I went for genetic counselling and testing and at that time it was for 176 genes known to be associated with retinal dystrophies. I believe that has now gone up to about 300, but at the time they couldn't recognise what my faulty gene was, and that has still been the case to my knowledge to date.   I have also been part of the 100,000 Genome Project along with several others of my wider family, and I am also a participant in the UK Inherited Retinal Dystrophy Consortium RP Genome Project, which has been sponsored by Retina UK. The impact of not having a positive genetic test result is quite interesting and has really been a rollercoaster. I guess it is all about hope, and to start with when I knew I was going to be genetically tested, I think my first reaction was optimism, and I think if you have a positive test result, that is a real hope for the future. I think that is quite exciting particularly as things seem to be progressing so rapidly. But because I didn't get a positive result, the next reaction I had really was disappointment because I felt one step behind people with a positive result. Of course the natural reactions are one of frustration, and then I guess followed by realisation of the situation, and heading towards trying to adjust and making coping strategies for the future.  I still feel that genetic testing for all forms of medical conditions is so important and has a huge future in understanding and then potential treatments for so many medical issues. I guess it might be a bit too late for me, but if I can contribute to finding a restorative treatment for the younger generations of my family, and for that matter other people, then I think that is good enough for me.   Naimah: So, we have just heard from Martin that although he has not been able to have a positive genetic test result, his involvement in various studies may have benefits in helping others find treatment. So, I guess on that point Bhavini, maybe you could comment, or ask you how you felt whenever you were about to get a diagnosis through whole genome sequencing?  Bhavini: Yes. When I got called in almost three and a half years after the testing that took place was a massive, massive relief because not only did I get genetic counselling before the testing period, but I got called in and I spoke to a genetic counsellor who explained what they had been able to find and what kind of RP it was, how it would progress, and just answer so many questions. I am the mother of two daughters and even having two children, I lost a lot of sight after my first daughter, but at that time there wasn't any evidence or there wasn't any … you know, there was nothing I even knew about what questions to ask or anything, so I did go on to have a second child and drastically lost more sight. I had always been told, because the lack of awareness and understanding of RP in my family, and I am one of four children, and I am the only one that has it, so there is no other family history. Now I know it could have skipped generations, but I was always told things like it was karma. I must have done something in my past life. I was told to kind of have these herbs or these remedies to cure my sight loss, you know my RP. I was even desperate enough to kind of …  all these bogues treatments that you find online. You know, anything. I was so desperate to find anything that would help me.   When I received that testing and the counselling, it explained so much about how my daughters may or may not be affected, how they are carriers, and that was explained to me, how it would progress. So many questions and worries that I had for almost a decade and a half, they were answered. And not only for me, for my family, and all those people that told me all these sorts of things that I used to worry about that could have caused my RP. I was able to explain it to them and they understood that it was nothing to do with me being bad in my past life. It was actually you know, there is something scientific about it. So, it kind of gave me lots and lots of answers, and actually I then created a private Facebook page just with my RP26 CERKL genetic that I have been diagnosed with, just to see if there is anybody else out there, because when I was diagnosed, I think at the time I was told there was only myself and nine other families in the UK diagnosed with this particular gene. Now, I haven't been that active on it, but you know there are people across the world who found my post and joined the group, and we share experiences about the age that we were kind of diagnosed, the kind of rate the symptoms have developed. It is so fascinating because we have got such similar experiences.   There is parents on there who are there on behalf of their children, and it is just so nice to see … I know it is RP, but the specific gene and the rate of which we have experienced all the symptoms, it is quite similar. So, it has been quite supportive and helpful and reassuring to my family including my daughters.  Naimah: That's incredible Bhavini and it's really nice that you have created that group and created kind of like a support network for all the other families that have been affected by the same genetic condition as well. Yeah, that's incredible. Gavin, I know the findings in the study show that the genetic changes in this study are more common in people of African and South Asian ancestry. So, so I want to understand why is this an impactful finding in the study?  Gavin: Yes, so Kate mentioned that around 30% of people with inherited retinal dystrophies who have genetic testing don't get a molecular diagnosis and we are working in my research lab and many other research labs to improve that. Now, that figure is very much higher in patients of for example African ancestry in the UK, and this is partly due to the fact that historically and even now genetic studies have been focused on European individuals and taken place in the US, and the UK, and Europe, and wealthy countries across the world. This means that people of African ancestry are poorly represented in genetic studies, not just genetic studies of genetic disease, but population studies as well. So, we have less of an understanding of the genetic variants found in the genomes of individuals of African ancestry. So, that means we solve less of the genetic cases, particularly at Moorfields we published a paper on this several years ago with the diagnostic rates in European patients versus those of African ancestry, and it was very, very much lower. So, we need to do better for those patients, and this study identified a cause of retinitis pigmentosa in 18 families of African ancestry who were recruited to the 100,000 Genomes Project.   This is a fairly large proportion of the patients with RP of African ancestry seen at Moorfields Eye Hospital, and when we contacted collaborators around the world many more families were identified, and I think we ended up publishing around about 40 families who were affected by this particular mutation. So, we can look at that variant, we can look at the DNA sequence around that variant, and we found there is a chunk of DNA around the mutation in the gene that was coinherited by all of those different individuals. So, this is what we call an ancestral haplotype. It's an ancient variant that goes back many, many generations and it has a fairly high carrier frequency in genomes of African ancestry. So, we think this will be a fairly significant cause of retinitis pigmentosa across the continent of Africa. And so, identifying it will enable us to provide a molecular diagnosis for those families. Potentially there will be many more families out there who don't know they have this cause of disease yet. They may be affected but they haven't yet received genetic testing.   But discoveries like this lead to better clinical management. We understand better the progression of the disease when we can study this in many individuals from a wide spectrum of ages and different backgrounds. We can provide counselling as Bhavini was talking about. We can provide patients with a better idea of what the future may hold for their eye disease, and potentially you know we are all aiming towards being able to develop therapies for particular genes and particular diseases. As Kate mentioned many of the gene therapies are gene specific, so if we identify a cause of disease that is predominant like this and affects many, many people, then of course there is more interest from the pharmaceutical industry to develop a therapy for that specific gene.  Naimah: Thanks Gavin. I think that really does showcase how impactful these findings really are. Kate, can I come to you. So, Gavin touched on it there that people with African and Asian ancestry are significantly less likely to get diagnosed, but why is it important to ensure that these groups are represented in the genomic datasets?  Kate: So, we need to ensure that genetic testing and diagnostic accuracy works for everyone, and not just those of European ancestry. So, as Gavin said if the datasets don't reflect the genetic variations seen in African or Asian populations, then the tests based on those data are more likely to give incomplete results for those groups of people. We really need a diverse range of genetic information for researchers to work on. As it is clear from this study's results, populations from African backgrounds for example may have unique genetic mutations linked to retinal dystrophy. So, if those are really underrepresented in datasets based on European populations, that is obviously going to present a problem. Gavin mentioned access to treatment. We need to overcome some of these disparities in healthcare access, and   inclusion of broad spectrum of genetic data is actually a foundation for that.   Naimah: Thanks Kate.  So underrepresented groups are often less likely to know about genetic testing due to a combination of social economic and systemic factors that create barriers to access information. Cultural taboos can also play a significant role in shaping attitudes towards genetic testing, and I think Bhavini you kind of touched on this slightly with some of your experiences. I wonder, did you experience any of these cultural taboos?  Bhavini: Yes, some of them, but I think by the time I was informed about what genetic testing and counselling is I had come across Retina UK and I had already started having that background knowledge, so when that was offered to me, I actually had a basic understanding. But as Chair of BAME Vision I work with a lot of ethnic communities, and when I speak about my own personal experience about receiving genetic testing and counselling, I kind of break it down into my own language, and the few common themes that always come out is people don't really understand what genetic testing and counselling is. They hear the word counselling, and they think it is the therapy that you receive counselling for your mental health or wellbeing.  So, again there is already a taboo around the terminology. Then it is lack of understanding and awareness, or where to get that information from. Also sometimes in different cultures, if you have been diagnosed with sight loss, you know blindness is one of the worst sensory things that people can be diagnosed with, so they try and hide it. They try and keep that individual at home, because they think they are going to have an outcaste in the community and the wider family, and you will be frowned upon, people will talk really bad.   So, it is not really common knowledge, so they don't even talk about it. So, there is a lot of layers to unpick there. That is one of the priority areas in 2025 that we at BAME Vision are going to be working on to try and raise that awareness in different communities about what genetic testing is, what it could mean, how to get genetic testing if it is not offered to you at your own clinic. There is a lot of work I know Retina UK have done, so working with them, and how we can reach different communities to raise that awareness.  Naimah: That's great. You have touched on how important the education piece is. I wonder, do you have any other examples of how healthcare providers and genetic counsellors might better engage communities to ensure that they are receiving the care that they need?  Bhavini: Yeah, absolutely. So, I think having information in different languages is essential, and I don't expect to have lots and lots of leaflets in different languages. Whether it is audio form or whether there is different professionals within that setting that speak different languages that can communicate to those patients, or even their family or friends that could translate. I think language is definitely something. And having representation, so like different people who have accessed this and sharing their story and going out into community groups and sort of sharing those messages, is definitely what has been working for us, and we have been doing that on other topics that we have used.  Naimah: Yes, they all sound like really important ways to try and engage with different communities. You have already mentioned how amazing that Retina UK have been and the support that you have received from them. So, I wonder Kate, if you could tell us a bit more about the support that is available for those with inherited sight loss, and how these resources can support people from underrepresented groups as well.  Kate: So, we have a range of support services at Retina UK most of which involve our fantastic team of volunteers, one of whom is Bhavini, who are all personally affected by inherited retinal dystrophy themselves. So, they are all experts by experience so to speak. The team also does include members of the Asian community as well. So, if somebody makes a call to our helpline, they will be able to speak to somebody who genuinely understands what they are going through, which can be a lifeline for those who are feeling isolated and especially I think as Bhavini mentioned, if they feel unable to talk openly with their own family and certainly within their community. We have a talk and support service that offers ongoing more regular telephone support as well as in-person and online peer support groups where people can make social connections with others in similar situations. I think Bhavini has mentioned that she herself runs our London and Southeast local group.  We also have an information resource called Unlock Genetics. That explains genetics in understandable language and clearly explains how people can access testing and what that will involve. So, we have stories on there from people who have gone through the process and talk about that. So, that is available on our website, and we can provide it in audio format as well.  Naimah: So Gavin, looking to the future, what does this research mean for patients with sight loss and their families? What does this mean in the future?  Gavin: So, I think now that we have access to whole genome sequencing through projects like the 100,000 Genomes Project, we are able to start the process of understanding new causes of disease that are found outside of the coded region.  So, we can now look for non-coding variants that cause disease which was previously not possible because genetic testing was focused on 2% of the genome. As we make discoveries like this these will inform future studies. So, the more we identify this type of variant and are able to functionally test the effect on the gene or the protein, we are able to use that information to lead future tests. What this needs is large population datasets to be able to analyse these sorts of variants at scale. The more genomes we have the better our understanding will be of our population frequencies, and the key thing is here for inherited retinal dystrophies, all of these variants that we are identifying are very, very rare. So, we only find them in a very small number of individuals affected with disease, and an infinitely smaller number of individuals in the unaffected general population. So, the larger that population dataset is that we can study, the better we can understand the rarity of these variants and pick those out from the many, many millions of non-pathogenic or harmless variants that we find in the genomes of all the individuals.  Naimah: Do you think the paper will help lead the way for diagnosis of other conditions in African and South Asian communities?    Gavin: Yes. The better we understand causes like this, and we are now at the point where most of the genes that cause retinal dystrophy have been identified already, so the remaining causes to be identified will be these more difficult to find cases, non-coding variants, structural variants, which we haven't touched on today which are larger rearrangements of the genome. These things are harder to find, harder to interpret, so the more that we find like this, the better our ability will be to interpret those sorts of variants. There are many similar findings coming out of genome studies like 100,000 Genomes Project. For example, there was a significant finding recently published on a non-coding RNU gene which causes a significant proportion of neurological disorders in the 100,000 Genomes Project. You need these studies to be able to drive forward the research in areas like this.   Naimah: Thanks Gavin, and the discovery that you are mentioning is the RNU4-2 gene that was discovered earlier this year. You can hear more about that on our other podcast on our website which is ‘How has groundbreaking genome work discovery impacted thousands far and wide' to learn more about that as well. But yeah, I agree it is another really great example of how impactful these findings can be. Okay, we'll wrap up there. Thank you to our guests Gavin Arno, Kate Arkell, and Bhavini Makwana for joining me today as we discussed the findings from a recent study which has identified genetic changes responsible for retinal dystrophy, and people commonly of South Asian and African ancestry. If you'd like to hear more like this, please subscribe to Behind the Genes on your favourite podcast app. Thank you for listening. I have been your host and producer, Naimah Callachand, and this podcast was edited by Bill Griffin of Ventoux Digital.

Considering recent cases and societal issues, how can built environment practitioners influence policies for women's safety in cities? With Professor Priti Parikh, Director of Bartlett School of Sustainable Construction, Dr Hanna Baumann, UCL Institute for Global Prosperity and Dr Margarita Garfias Royo, Deputy Director of the Engineering for International Development Centre.  Transcription link: https://bartlett-review.ucl.ac.uk/podcast-planning-urban-environments-for-womens-safety/index.html Date of episode recording: 2024-12-12T00:00:00Z Duration: 00:33:57 Language of episode: English Presenter:Professor Priti Parikh Guests: Dr Hanna Baumann; Dr Margarita Garfias Royo Producer: Adam Batstone, Chizoba Onyiuke and Victoria Howard

Today we are continuing our discussion on gene therapy, with Dr Rajvinder Karda, hosted by Olivia. Raj is both a researcher and professor at the UCL Institute for Women's Health, with her role as an associate professor of Gene Therapy, as well as leading a team of research focussing on developing pre-clinical gene therapy and RNA editing treatments for childhood epilepsy, including Dravet Syndrome. Listen in to learn more about Raj's work in the field of gene therapy, as she explains more about how gene therapies are being researched and developed for pre-clinical trials, including in her lab where her team is working on the development of gene therapies for treating Dravet Syndrome. Date of episode recording: 2025-01-22T00:00:00Z Duration: 00:30:16 Language of episode: English Presenter:Olivia Moir Guests: Dr Rajvinder Karda Producer: Olivia, UCL Institute for Women's Health, UCL Faculty of Population Health Sciences

While paediatric onset multiple sclerosis is relatively rare, it presents unique challenges. Extensive research efforts are taking place around the world to better understand the disease mechanism of paediatric MS and the similarities and differences that exist with adult onset MS to help determine the best treatment options for children and adolescents. In this episode, host Brett Drummond of MSTranslate explores the topic with Dr. Yael Hacohen of Great Ormond Street Hospital for Children and UCL Institute of Neurology in the UK and Dr. Thaís Armangué of SJD Barcelona Children's Hospital in Spain.

Join co hosts Graham Stanley and James Radburn for this one off special delving into the lives of teachers who have transitioned from the classroom into the world of edtech. Find out more about Toddle by visiting toddleapp.com. They are joined by two guests... Deepanshu Arora -  Deepanshu is the Co-founder and CEO of Toddle, an AI-powered teaching & learning platform loved by 2,000+ progressive schools around the world. An engineer by background and an educator by passion, he believes that technology has only one role to play in education - that of helping teachers do better what they do best. Deepanshu also leads Toddler's Den, a network of Reggio Inspired Preschools. Prior to this, he worked with McKinsey & Company and studied at the Indian Institute of Technology. Matt Fletcher - Matt Fletcher holds a degree in English Literature from the University of Sussex and completed his PGCE in Secondary Education at the UCL Institute of Education. As a fellow of the Inspiring Teachers programme, he spent time in Uganda last year, working with teachers in low-resource contexts and helping design a peer-coaching programme. Prior to joining Toddle, Matt taught English at The Harrodian School in Barnes. Now, Matt leads regional growth for Toddle in the UK and is driven by his passion for integrating technology to support teachers, ease administrative workloads and enhance learning outcomes. His aim is to empower teachers with innovative digital tools that enable them to thrive in today's evolving educational landscape.

On this episode of Mind the Gap, Jon Hutchinson and Emma Turner are joined by Leora Cruddas, CEO of the Confederation of School Trusts. Leora shares her journey from teaching in apartheid-era South Africa to becoming a leading voice in educational policy and academy trust leadership. Together, they explore the evolution of academy trusts, the importance of stable leadership, and the challenges of teacher recruitment and retention. Leora highlights the role of trusts as civic anchors, emphasizing their capacity to foster collaboration and serve as pillars of community well-being. She says, "The point at which we start making decisions on behalf of our children from the vested interests of adults is the point that our education system will start to fail." Reflecting on her role, Leora underscores the need for educational leaders to balance stability with innovation, as well as the need for trust leaders to tell adopt a narrative around trusts that focuses on the moral purpose of education. The discussion concludes with a compelling vision for the future of education: building systems that prioritize public trust, equity, and human flourishing. Leora Cruddas is the founding Chief Executive of the Confederation of School Trusts – the national organisation and sector body for school trusts in England. She has advised successive governments and sits on several Department for Education advisory bodies. She was recently the vice chair of the Head Teacher Standards Review Group, a member of the external advisory group for the Schools White Paper, SEND National Implementation Board and the Regulatory and Commissioning Review. Prior to founding CST, she was Director of Policy and Public Relations for the Association of School and College Leaders. Leora has six years of experience as a director of education in two London local authorities. She is a visiting professor at UCL Institute of Education, and was made a CBE in the 2022 New Year's Honours. Follow her on X @LeoraCruddas. Emma Turner FCCT is a school improvement advisor, education consultant, trainer and author. She has almost three decades of primary teaching, headship and leadership experience across the sector, working and leading in both MATs and LAs. She works nationally and internationally on school improvement including at single school level and at scale. She has a particular interest in research informed practice in the primary phase, early career development, and CPD design. Follow Emma on X ⁠⁠⁠⁠⁠⁠⁠⁠⁠@emma_turner75⁠⁠⁠⁠⁠⁠⁠⁠⁠. Jon Hutchinson is a former assistant headteacher of Reach Academy Feltham and is now a Director at the Reach Foundation. He has taught across primary and secondary and HE. In his spare time, Jon runs ⁠⁠www.meno.acacdemy⁠⁠, a platform with free videos to support primary teachers to build their subject knowledge. Follow Jon on X ⁠⁠⁠⁠@jon_hutchinson_⁠⁠ or Bluesky ⁠⁠@jonhutchinson.bksy.social⁠. This podcast is produced by Haringey Education Partnership. Find out more at ⁠⁠⁠⁠⁠⁠⁠⁠https://haringeyeducationpartnership.co.uk/

The Education Brief: Saturday 23 November 2024 - Top stories include: A new Teaching Commission aims to address the teacher recruitment and retention crisis. Ambition Institute, Education Development Trust, Teach First, and UCL Institute of Education secured contracts to deliver the Early Career Framework from 2025. A report on the Behaviour Hubs programme reveals contrasting outcomes. The government has commissioned research into the Safety Valve scheme's effects on children and families. This week's deep dive:  New Data on Suspensions and Exclusions We'll also tell you what's happening at HEP this week and what we've been watching, listening to, and reading! Watching - https://fairnessfoundation.com/posts/great-britain Listening - https://podcasts.apple.com/gb/podcast/the-wellbeing-equation-why-happy-staff-stay-with/id1608692574?i=1000673251399 Reading - https://www.mqmentalhealth.org/mental-health-and-the-internet/ AI Tool - https://www.blooket.com/ Music by Slo Pony

Watch the Q&A session here:  https://youtu.be/leCxdECjyDMReducing health inequalities is a matter of social justice. Strategies must address the social gradient in health, and efforts should extend beyond healthcare to address the conditions in which people are born, grow, live, work, and age. This lecture argues economic circumstances, while important, are not the sole drivers of health inequalities, and closing the health gap will take evidence-based action across the whole of society.This lecture was recorded by Michael Marmot  on 6th November 2024 at Barnard's Inn Hall, London.Sir Michael Marmot has been Professor of Epidemiology at University College London since 1985, and is Director of the UCL Institute of Health Equity. He served as President of the British Medical Association (BMA) in 2010-2011, and as President of the World Medical Association in 2015.  He is President of the Asthma + Lung UK.  He is a Fellow of the Academy of Medical Sciences and Honorary Fellow of the American College of Epidemiology and of the Faculty of Public Health; an Honorary Fellow of the British Academy; and of the Royal Colleges of Obstetrics and Gynaecology, Psychiatry, Paediatrics and Child Health, and General Practitioners.The transcript of the lecture is available from the Gresham College website: https://www.gresham.ac.uk/watch-now/health-gapGresham College has offered free public lectures for over 400 years, thanks to the generosity of our supporters. There are currently over 2,500 lectures free to access. We believe that everyone should have the opportunity to learn from some of the greatest minds. To support Gresham's mission, please consider making a donation: https://gresham.ac.uk/support/Website:  https://gresham.ac.ukTwitter:  https://twitter.com/greshamcollegeFacebook: https://facebook.com/greshamcollegeInstagram: https://instagram.com/greshamcollegeSupport the show

How can NHS backlogs be tackled and waiting times improved? What are the prospects for adult social care reform in this parliament? How can government ensure health and care services have sufficient workforces? Do health and care services have sufficient funding and is existing funding used effectively? To what extent can and should health services focus more on prevention? And to what extent do the government's proposals address these challenges? Dr Becks Fisher, Director of Research and Policy at Nuffield Trust Professor Naomi Fulop, Professor of Health Care Organisation and Management at the UCL Institute of Epidemiology and Health Care Preet Gill MP, former Shadow Minister for Primary Care and Public Health Dame Una O'Brien, former Permanent Secretary in the Department of Health This session was chaired by Stuart Hoddinott, Senior Researcher at the Institute for Government. This event was part of the IfG's public services conference, kindly supported by UCL.

On 30 October, the new government announced spending plans for 2025/26, with a spending review covering 2025/26 to 2027/28 due to be published in the spring. What are the implications of these spending plans for public service performance in 2025/26? What options should the spending review consider for raising revenue and boosting productivity? How can the government improve public services when funding is tight? Rupert Harrison, former Chief of Staff to George Osborne and Chair of the UK's Council of Economic Advisors (2010–15) Paul Johnson, Director of the Institute for Fiscal Studies Professor Henrietta Moore, Founder and Director of the UCL Institute for Global Prosperity Rachel Sylvester, political columnist at The Times and Chair of the Times Health Commission This session will be chaired by Nick Davies, Programme Director at the Institute for Government. This event was part of the IfG's public services conference, kindly supported by UCL.

How can NHS backlogs be tackled and waiting times improved? What are the prospects for adult social care reform in this parliament? How can government ensure health and care services have sufficient workforces? Do health and care services have sufficient funding and is existing funding used effectively? To what extent can and should health services focus more on prevention? And to what extent do the government's proposals address these challenges?   Dr Becks Fisher, Director of Research and Policy at Nuffield Trust Professor Naomi Fulop, Professor of Health Care Organisation and Management at the UCL Institute of Epidemiology and Health Care  Preet Gill MP, former Shadow Minister for Primary Care and Public Health Dame Una O'Brien, former Permanent Secretary in the Department of Health    This session was chaired by Stuart Hoddinott, Senior Researcher at the Institute for Government. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Professor Monica Lakhanpaul and Professor Priti Parikh are joined by Professor Catalina Turcu, Professor of Sustainable Built Environment, Bartlett School of Planning and Professor Ilan Kelman, Professor of Disasters and Health in the UCL Institute for Risk and Disaster Reduction. Today they're discussing the relationship between the Sustainable Development Goals and climate change. Goal 13 calls for urgent action to combat climate change and its impacts, and many people have argued that tackling climate change should be the highest priority of the goals because of its impact on all of the other targets. Date of episode recording: 2024-07-23T00:00:00Z Duration: 00:44:36 Language of episode: English Presenter:Professor Monica Lakhanpaul, Professor Priti Parikh Guests: Professor Catalina Turcu, Professor Ilan Kelman Producer: Front Ear

What does culture mean to you? Is it the art we create, the traditions we carry, or the values we hold dear? In this mini episode of Our World, Connected, Christine Wilson, Director of Research and Insight at the British Council, delves deeper into the multifaceted nature of culture and its incredible power to connect, inspire, and heal.  Christine revisits some of the most impactful conversations from the first season, featuring insights from Alexandra Xanthaki, UN Special Rapporteur on Cultural Rights, Scott Orr, a data scientist from the UCL Institute of Sustainable Heritage, David Watson, the Executive Director of Audiences and Media at National Museums Liverpool, and Hala Nur, a British Council colleague working in Sudan. Together, they discuss how culture transcends borders, linking people through shared values, language, art, and traditions. From the Eurovision Song Contest's unifying magic to the profound connection between culture and the environment, we unpack how culture shapes our world and fosters a deep sense of belonging. This is the first of a 3-part mini-series we're putting together as we prepare for Season 2 of Our World, Connected, coming this January. Episodes Featured: Is culture the missing key to global progress? United by music: Lessons from Eurovision 2023 Climate Change and Cultural Heritage: Protecting our Past and Future Culture and Education: Seeds of Hope in Times of Conflict Follow British Council Research and Insight: Newsletter – https://www.britishcouncil.org/research-insight/subscribe  Twitter – https://twitter.com/InsightBritish  Website - https://www.britishcouncil.org/research-insight 

Catherine Gray, the host of Invest In Her, interviews Dr Kristen Weatherby,  the founder of Breakthrough Labs, an accelerator and community supporting female tech founders seeking early-stage funding. Breakthrough Labs addresses the unique challenges that women encounter on their entrepreneurship journeys and offers research-backed support to ensure that more female-founded start-ups thrive. The new Breakthrough Labs online community supports women entrepreneurs globally by providing them access to the learning, connections, and resources they need to help their businesses thrive. Dr Weatherby is also a Scout for Ada Ventures, an impact-driven VC committed to funding diverse founders in the UK. She has a PhD in education technology from the UCL Institute of Education, and a Masters in Education from the University of Michigan. Her 25-year career has included leadership roles in some of the largest global public and private sector players in education, technology, policy, and research, including Microsoft, the OECD, and University College London.    https://www.breakthroughlabs.net/ www.sheangelinvestors.com    Follow Us On Social Facebook | Instagram | Twitter | LinkedIn  

This week, Jonathan is joined by Mandeep Sagoo, Professor of Ophthalmology and Ocular Oncology, UCL Institute of Ophthalmology, London, UK. The pair explore ocular oncology and Mandeep's groundbreaking work developing a digitally engineered 3D printed ocular prosthetic.   Use the following timestamps to navigate this episode:  (00:00)-Introduction (04:17)-Mandeep's journey into ophthalmology (08:06)-Pioneering work in Philadelphia, USA (11:15)-Lessons from the US healthcare system (13:30)-Churchill's Fellow Award (16:25)-Naevi and the role of ocular coherence tomography (20:00)-How to diagnose malignancies (30:38)-Creating prosthetic eyes following enucleation (34:06)-3D printed prosthetics (39:28)-Retinoblastoma (42:45)-Innovations in molecular medicine (44:42)-Three wishes for ocular oncology  

Welcome to Series 5! In this first episode, following the recent Labour party conference, our hosts Professor Mark Maslin and Dr Simon Chin-Yee discuss the UK government's plan to create ‘Great British energy'. The (not so?) ambitious programme aims to make Britain a clean energy superpower to bolster energy security and achieve its net zero carbon emissions target by 2050. But how impactful actually are these policies? With UCL's Professor of Energy Policy Jim Watson, Emma Fletcher from Octopus Energy, and Dave Powell from Climate Outreach, we assess whether this is a genuine step towards green energy or just political rhetoric. Our experts also look more broadly at green initiatives, and whether they really can lower your bills. Date of episode recording: Monday 16th and 17th September 2024 Duration: 49.55 minutes Language of episode: English  Presenter: Professor Mark Maslin and Dr Simon Chin-Yee  Guests: Emma Fletcher (Low Carbon Homes Director of Octopus Energy) Dave Powell (Senior Advocacy Manager at Climate Outreach) Jim Watson (Professor of Energy Policy and Director of UCL Institute of Sustainable Resources within the Faculty of the Built Environment) Producer: Adam Batstone

Jeannette is joined by Professor Anthony Khawaja, a top eye specialist at Moorfields, focusing on the topic of glaucoma. Professor Kawaja shares his journey to becoming a leading expert in the field of ophthalmology, highlighting the importance of early detection and treatment of glaucoma. He discusses the impact of genetics, lifestyle choices, and advancements in artificial intelligence on eye health KEY TAKEAWAYS Anthony's innovative approach to combining medicine and surgery in the field of ophthalmology, particularly in glaucoma, showcases his commitment to finding new solutions. Professor Khawaja's groundbreaking genetic research in glaucoma has led to significant advancements in understanding the disease and potential treatments. The emphasis on making a difference and impacting society through his work is a driving force for Professor Kawaja, motivating him to push boundaries and challenge the status quo. The importance of finding a balance between work and personal life, as well as the support of a partner like Claire, is crucial for managing the emotional toll of challenging cases and maintaining fulfilment in one's career. BEST MOMENTS "It's moved so quickly. I remember when I first started ophthalmology for some inherited, I did a clinic, you only get these clinics at Northfields where everybody has these rare genetic dystrophies" "In some cases you're dealing with death, you're dealing with potential blindness in your field."  "Glaucoma is what commonest causes of blindness. In the UK and in developed countries it's usually the second commonest cause after a condition called age-related macular degeneration."   This is the perfect time to get focused on what YOU want to really achieve in your business, career, and life. It's never too late to be BRAVE and BOLD and unlock your inner BRILLIANT. Visit our new website https://brave-bold-brilliant.com/ - there you'll find a library of FREE resources and downloadable guides and e-books to help you along your journey. If you'd like to jump on a free mentoring session just DM Jeannette at info@brave-bold-brilliant.com. VALUABLE RESOURCES Brave Bold Brilliant - https://brave-bold-brilliant.com/ Brave, Bold, Brilliant podcast series - https://podcasts.apple.com/gb/podcast/brave-bold-brilliant-podcast/id1524278970    ABOUT THE GUEST Professor Anthony Khawaja leads a data science and genomics research team at the UCL Institute of Ophthalmology and Moorfields Eye Hospital, aiming to improve the care of patients with glaucoma and other common eye diseases. He is an Honorary Consultant Ophthalmic Surgeon practicing at Moorfields Eye Hospital, where he specialises in the medical and surgical care of patients with glaucoma and cataract. Anthony completed his medical training at the University of Cambridge and University College London, and his ophthalmic residency and glaucoma fellowship training at Moorfields Eye Hospital. His research training began with a Wellcome Trust funded PhD programme at the University of Cambridge, including a Masters in Epidemiology for which he won the Nick Day Prize. He was also awarded the Berkeley Fellowship which supported a period at Harvard Medical School. Anthony is currently a UK Research & Innovation Future Leaders Fellow and a Lister Institute Fellow. He holds several leadership positions including: Director of the European Society of Ophthalmology Leadership Development Programme, President of the European Eye Epidemiology Consortium, Chair of the European Glaucoma Society Screening Task Force, Chair of the Royal College of Ophthalmologists Informatics and Audit Committee, Chair of the UK Glaucoma Genetics Consortium, Chair of the UK Glaucoma Real-World Data Consortium. ABOUT THE HOST Jeannette Linfoot is a highly regarded senior executive, property investor, board advisor, and business mentor with over 30 years of global professional business experience across the travel, leisure, hospitality, and property sectors. Having bought, ran, and sold businesses all over the world, Jeannette now has a portfolio of her own businesses and also advises and mentors other business leaders to drive forward their strategies as well as their own personal development. Jeannette is a down-to-earth leader, a passionate champion for diversity & inclusion, and a huge advocate of nurturing talent so every person can unleash their full potential and live their dreams. CONTACT THE HOST Jeannette's linktree - https://linktr.ee/JLinfoot https://www.jeannettelinfootassociates.com/ YOUTUBE - https://www.youtube.com/@braveboldbrilliant LinkedIn - https://uk.linkedin.com/in/jeannettelinfoot Facebook - https://www.facebook.com/jeannette.linfoot/ Instagram - https://www.instagram.com/jeannette.linfoot/ Tiktok - https://www.tiktok.com/@jeannette.linfoot Podcast Description Jeannette Linfoot talks to incredible people about their experiences of being Brave, Bold & Brilliant, which have allowed them to unleash their full potential in business, their careers, and life in general. From the boardroom tables of ‘big' international businesses to the dining room tables of entrepreneurial start-ups, how to overcome challenges, embrace opportunities and take risks, whilst staying ‘true' to yourself is the order of the day.Travel, Bold, Brilliant, business, growth, scale, marketing, investment, investing, entrepreneurship, coach, consultant, mindset, six figures, seven figures, travel, industry, ROI, B2B, inspirational: https://linktr.ee/JLinfoot

One in six people are said to have ‘very poor literacy skills' according to the National Literacy Trust. As a country, we value Literature, high quality research skills and further education, yet our values are not reaching all sections of our society. Looking to challenge this is Professor Anna Vignoles, her past research focused on issues of equity and value in education, particularly the relationship between educational achievement and social mobility, and the role played by education and skills attainment in the economy and society.   She was Professor of Education and Fellow of Jesus College at the University of Cambridge, Professor of Economics of Education at the UCL Institute of Education and Research Fellow at the London School of Economics Centre for Economic Performance. But now, Professor Vignoles is the Director of the Leverhulme Trust, one of the UK's most prestigious grant-making organisations.  Season 6 of the We Society Podcast from the Academy of Social Sciences continues to tackle the big questions through a social science lens. Throughout this series, you'll be hearing some of the best ideas to shape the way we live. Hosted by journalist and Academy President Will Hutton, we interview some of Britain's top social scientists and public figures from across the globe to explore their evidence-led solutions to society's most pressing problems. Don't want to miss an episode? Follow the We Society on your favourite podcast platform and you can email us on wesociety@acss.org.uk and tell us who we should be speaking to or follow us on X https://twitter.com/AcadSocSciences Find out more about the Academy of Social Sciences here: https://AcSS.org.uk

Ed has departed for government, and Geoff is left as custodian of the archive. As the Labour government makes its first raft of announcements and appointments, we delve into our back catalogue to find the ideas which might have influenced them. In this episode, we look at Rachel Reeves' announcement of the National Wealth Fund. What are public wealth funds? What different forms can they take? What are the potential benefits to our country?We revisit our episode Investment for the People from October 2022. First, we get the beginner's guide from UCL Associate Professor Josh Ryan-Collins. Then we hear from Professor Karin Thorburn about Norway's Sovereign Wealth Fund, which (due to specific historical circumstances) is very different to the one proposed for the UK, but illustrates how a public wealth fund could transform the way we finance Government spending. More infoNorway's Sovereign Wealth FundUCL IIPP Report on Public Wealth FundsGuestsJosh Ryan-Collins, Associate Professor in Economics and Finance, UCL Institute for Innovation and Public Purpose (@jryancollins) (@IIPP_UCL)Karin Thorburn, Professor of Finance, Norwegian School of Economics (@karinsthorburn) (@NHHnor) Hosted on Acast. See acast.com/privacy for more information.

As the sun sets on the longest day of the year, Matthew Sweet talks to an eclectic group of guests about the illusion of time, the summer solstice and the philosophy of comedy. They are: Materials scientist & engineer; Director of the UCL Institute of Making; Author of Stuff Matters and other book Mark Miodownik. Philosopher Emily Herring who is about to publish the first English biography of the french philosopher Henri Bergson who was famous for his theory of time as well as his views on the meaning of comedy. Emily's book Herald of a Restless World: How Henri Bergson Brought Philosophy to the People is out in October. Comedian Rob Newman who made his name with the Mary Whitehouse Experience in the 90s and has presented two series on BBC Radio 4 including Rob Newman's Half-full Philosophy Hour. Also Professor of theoretical physics at Imperial College London Fay Dowker who is an expert in Causal Set Theory and Quantum Relativity. And Author K A Laity will talk about the Women in Magick Conference being held in Birmingham this weekend. Producer: Lisa Jenkinson

Jenny and Liz talk to Dr Marysia Tarnowska about their journey into heritage science from a background in chemistry: from molecular bonds to leather deterioration! Jenny also talks to Dr Josep Grau-Bove from the Icon Heritage Science Group about how we can communicate better as both conservators and scientists. Finally, tune in for a review of ‘Soft Paint and the Care of Paintings' from Liz! 00:01:10 From chemistry to museum adventures 00:07:35 A project is born 00:14:53 Scientific papers are an endurance sport 00:17:23 Ways into heritage science 00:19:08 Communicating with conservators 00:24:02 Reaching scientists early on 00:34:28 Museums doing research 00:40:53 Getting involved with scientists 00:43:42 University is where it's at 00:47:13 Don't forget about the Marsh Awards 00:48:00 Patreon shout-out 00:48:37 Interview with Dr Josep Grau-Bove 01:03:11 Review: Soft Paint and the Care of Paintings Show Notes: - Find Marysia on LinkedIn: https://www.linkedin.com/in/marysia-tarnowska/ - Follow Marysia on Twitter: https://twitter.com/supra_marysia - Blog entry by Lucia Burgio at the V&A: https://www.vam.ac.uk/blog/caring-for-our-collections/a-week-in-the-life-of-a-va-heritage-scientist-intro - Red rot (Wikipedia): https://en.wikipedia.org/wiki/Red_rot - Museum of Leathercraft: https://museumofleathercraft.org/ - Leather Conservation Centre: https://leatherconservation.org/ - Institute for Creative Leather Technologies: https://www.northampton.ac.uk/research/research-institutes-and-centres/institute-for-creative-leather-technologies/ - S09E06 Leather: https://thecword.show/2021/06/02/s09e06-leather/ - ICPMS: https://en.wikipedia.org/wiki/Inductively_coupled_plasma_mass_spectrometry - /r/ArtConservation: https://www.reddit.com/r/ArtConservation/ - Icon Heritage Science Group: https://www.icon.org.uk/groups-and-networks/heritage-science.html - European Research Infrastructure for Heritage Science (E-RIHS): https://www.e-rihs.eu/ - MoLab: https://www.iperionhs.eu/molab/ - AHRC (Arts and Humanities Research Council): https://www.ukri.org/councils/ahrc/ - Research at Amgueddfa Cymru: https://museum.wales/research/ - Cultural Heritage Agency of the Netherlands: https://english.cultureelerfgoed.nl/ - Marsh Conservation Awards 2024: https://www.icon.org.uk/impact/the-marsh-conservation-awards.html - Dr Josep Grau-Bove at UCL: https://profiles.ucl.ac.uk/33855-josep-graubove - UCL Institute for Sustainable Heritage: https://www.ucl.ac.uk/bartlett/heritage/ucl-institute-sustainable-heritage - Dr Katherine Curran at UCL: https://profiles.ucl.ac.uk/34356-katherine-curran/ - Soft Paint and the Care of Paintings book: https://archetype.co.uk/our-titles/soft-paint-and-the-care-of-paintings/?id=450 Previous ‘Working With' episodes: - S07E04 Working With Techs: https://thecword.show/2020/05/27/s07e04-working-with-techs/ - S09E01 Working With Front of House: https://thecword.show/2021/03/24/s09e01-working-with-front-of-house/ - S10E02 Working With Curators: https://thecword.show/2021/09/29/s10e02-working-with-curators/ - S11E03 Working With Learning: https://thecword.show/2022/04/20/s11e03-working-with-learning/ - S13E04 Working With Adult Learning: https://thecword.show/2023/05/03/s13e04-working-with-adult-learning/ Support us on Patreon! http://www.patreon.com/thecword Hosted by Liz Hébert, Jenny Mathiasson, and Dr Marysia Tarnowska. Intro and outro music by DDmyzik, used under a Creative Commons Attribution license. Made available under a Creative Commons Attribution-NonCommercial 4.0 International license. A Wooden Dice production, 2024.

This episode we explore Positive Impact. UCLB is helping to create a new generation of businesses from UCL academics specifically with positive societal impact at their heart. The commercialisation process can be a long road requiring financial, legal, and practical support. Nigel Campbell meets two inventors, Buffy Price Co-founder and COO of Carbon Re, an AI and Climate Tech company spinout from UCL and Cambridge, and Professor Pete Coffey from UCL Institute of Ophthalmology and Founder of Tenpoint Therapeutics; both who are on that journey on how their inventions might improve our future world. We also talk to Dr Anne Lane, CEO of UCLB to find out how UCLB finds the bright ideas which will improve lives, and what it takes to scale to a point where they are having true impact. For more information and transcript: https://www.uclb.com/event-category/podcast/

Michael Marmot, Professor of Epidemiology at University College London, Director of the UCL Institute of Health Equity, and Past President of the World Medical Association, joins Gavin and Jessamy to discuss the centrality of health issues to UK politics, what the upcoming election should be fought on, and the role of equity and equality in UK health outcomes.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Today, we look at rising cases of measles in the UK, and a huge boost to Trump's presidential campaign. As the government launches a catch up campaign for missed MMR Vaccines - we ask why are so many children not being vaccinated? It comes as the West Midlands has seen more than 200 cases of measles since 1st of October. James talks to Preet Kaur Gill, Labour MP for Birmingham Edgbaston, and Helen Bedford, Professor of Children's Health at UCL Institute of Child Health.And in the US, Florida Governor Ron DeSantis has dropped out the race to become the Republican presidential nominee, endorsing Mr Trump. Is the race to challenge Joe Biden effectively over? BBC US Special Correspondent, Katty Kay, brings us the latest from the campaign trail. You can join our Newscast online community here: https://tinyurl.com/newscastcommunityhere Newscast brings you daily analysis of the latest political news stories from the BBC. It was presented by James Cook. It was made by Jack Maclaren with Sam McLaren and Joe Wilkinson. The technical producer was Gareth Jones. The senior news editors are Jonathan Aspinwall and Sam Bonham.

Researchers from University College London have developed an electrocardiographic imaging (ECGI) vest that might help identify individuals at a higher risk of sudden cardiac death. Joining Jonathan to explain how it works is Gaby Captur, Consultant cardiologist in Inherited Heart Muscle Conditions at the Royal Free London NHS Foundation Trust & Senior lecturer at the UCL Institute of Cardiovascular Science.

In this episode you will learn the following:   Childhood development starts in the womb and is critically important until age 2 to set the foundation for who your baby can possibly be.   Your baby is communicating with you through every sound they make. The parents' role is to communicate back.   The games parents play with their newborns each have a learning function to them.   It's important that parents discuss what is priority to them in how they raise their child before having children.   Consistency provides a safe and secure environment for children. Each parent's daily routine is important when there is co-parenting in two households due to divorce.   Don't Compete! Each co-parent is different and each co-parent has value in what they can provide to their children.   The Oliiki app is designed to create daily interactions with children up to 24 months old that explain the developmental skill the baby is learning.   Oliiki is grounded in science.  UCL Institute of Education carried out a randomised controlled trial on the Oliiki app and found that parents using the Oliiki app after only 4 weeks had higher parental self-efficacy, (more confident in their parenting) compared to the active control trial. This is significant because high parental self-efficacy is connected with low post-natal depression, low infant mental health issues and high home learning environments.   #coparenting #parenting #education #play #communication #divorce #podcast #divorcepodcast  #amicabledivorce #prenatalcommunication #childhooddevelopment #Oliikiapp #therapy #consistency #newborns #familytherapy @ClareStead @JenJackson About Clare Stead Clare Stead, Creator and Founder of the Oliiki app is an e-Learning specialist, Education researcher and primary teacher. She is passionate about helping parents and careers build their baby's brains from conception onwards, so the children reach their full potential and fly. Supporting parents early gives them the confidence to know they're doing the very best for their baby, developing knowledge and skills in play-based learning for our youngest child helps them ensure they thrive, right from the start.    https://www.linkedin.com/in/clarestead-oliiki/ www.oliikiapp.com Download the Oliiki app here https://www.instagram.com/oliiki/ https://www.facebook.com/Oliiki   Oliiki app blurb   The Oliiki app is an app for parents and parents-to-be of babies in the first 1000 days, from conception to two to build their babies brain and spark their parenting confidence one play activity at a time.   Jen Jackson   Jen has accumulated 18 years of experience in the healthcare industry and currently serves as an ambassador for healthy youth development within managed care organizations. Her primary professional focus involves identifying innovative approaches to promote youth's mental health and effectively communicating product differentiators that impact the health and well-being of members.   Jen initiated her career as a mental health therapist, providing services to children, teenagers, and families in various settings, including acute care, county mental health agency, and private practice. She holds a master's degree in social work from Temple University and is a Licensed Clinical Social worker in the state of Utah. In 2005, Jen earned credentials as a Registered Play Therapist.   www.linkedin.com/in/jenniferannjackson jj.jenniferannjackson@gmail.com

------------------Support the channel------------ Patreon: https://www.patreon.com/thedissenter PayPal: paypal.me/thedissenter PayPal Subscription 3 Dollars: https://tinyurl.com/ybn6bg9l PayPal Subscription 5 Dollars: https://tinyurl.com/ycmr9gpz PayPal Subscription 10 Dollars: https://tinyurl.com/y9r3fc9m PayPal Subscription 20 Dollars: https://tinyurl.com/y95uvkao   ------------------Follow me on--------------------- Twitter: https://twitter.com/TheDissenterYT   This show is sponsored by Enlites, Learning & Development done differently. Check the website here: http://enlites.com/   Dr. Uta Frith is Emeritus Professor of Cognitive Development at UCL Institute of Cognitive Neuroscience since 2006. She has been a Visiting Professor at the University of Aarhus at the Interacting Minds Centre from 2007 to 2015. She has been a Fellow at the Institute for Advanced Studies at the Central European University in Budapest (February - June 2014). Dr. Chris Frith is Emeritus Professor of Neuropsychology at the Wellcome Trust Centre for Neuroimaging at University College London, Visiting Professor at the Interacting Minds Centre at Aarhus University, Research Fellow at the Institute of Philosophy, and Quondam Fellow of All Souls College, Oxford. They are authors of “What Makes Us Social?”.   In this episode, we focus on “What Makes Us Social?”. We start by discussing what social cognition is, and then go through topics like learning and imitation; emotions, our need to affiliate, and joint action; predicting other people's behavior; group identity; reputation; trust; mentalizing; how high-level cognitive processes interact with low-level cognitive processes; consciousness; collective problem-solving; and teaching, cumulative culture, and the role of culture in human cognition. Finally, we discuss how we can foster cooperation. -- A HUGE THANK YOU TO MY PATRONS/SUPPORTERS: PER HELGE LARSEN, JERRY MULLER, HANS FREDRIK SUNDE, BERNARDO SEIXAS, OLAF ALEX, ADAM KESSEL, MATTHEW WHITINGBIRD, ARNAUD WOLFF, TIM HOLLOSY, HENRIK AHLENIUS, JOHN CONNORS, FILIP FORS CONNOLLY, DAN DEMETRIOU, ROBERT WINDHAGER, RUI INACIO, ZOOP, MARCO NEVES, COLIN HOLBROOK, PHIL KAVANAGH, SAMUEL ANDREEFF, FRANCIS FORDE, TIAGO NUNES, FERGAL CUSSEN, HAL HERZOG, NUNO MACHADO, JONATHAN LEIBRANT, JOÃO LINHARES, STANTON T, SAMUEL CORREA, ERIK HAINES, MARK SMITH, JOÃO EIRA, TOM HUMMEL, SARDUS FRANCE, DAVID SLOAN WILSON, YACILA DEZA-ARAUJO, ROMAIN ROCH, DIEGO LONDOÑO CORREA, YANICK PUNTER, ADANER USMANI, CHARLOTTE BLEASE, NICOLE BARBARO, ADAM HUNT, PAWEL OSTASZEWSKI, NELLEKE BAK, GUY MADISON, GARY G HELLMANN, SAIMA AFZAL, ADRIAN JAEGGI, PAULO TOLENTINO, JOÃO BARBOSA, JULIAN PRICE, EDWARD HALL, HEDIN BRØNNER, DOUGLAS FRY, FRANCA BORTOLOTTI, GABRIEL PONS CORTÈS, URSULA LITZCKE, SCOTT, ZACHARY FISH, TIM DUFFY, SUNNY SMITH, JON WISMAN, DANIEL FRIEDMAN, WILLIAM BUCKNER, PAUL-GEORGE ARNAUD, LUKE GLOWACKI, GEORGIOS THEOPHANOUS, CHRIS WILLIAMSON, PETER WOLOSZYN, DAVID WILLIAMS, DIOGO COSTA, ANTON ERIKSSON, CHARLES MOREY, ALEX CHAU, AMAURI MARTÍNEZ, CORALIE CHEVALLIER, BANGALORE ATHEISTS, LARRY D. LEE JR., OLD HERRINGBONE, MICHAEL BAILEY, DAN SPERBER, ROBERT GRESSIS, IGOR N, JEFF MCMAHAN, JAKE ZUEHL, BARNABAS RADICS, MARK CAMPBELL, TOMAS DAUBNER, LUKE NISSEN, KIMBERLY JOHNSON, BENJAMIN GELBART, JESSICA NOWICKI, LINDA BRANDIN, NIKLAS CARLSSON, ISMAËL BENSLIMANE, GEORGE CHORIATIS, VALENTIN STEINMANN, PER KRAULIS, KATE VON GOELER, ALEXANDER HUBBARD, LIAM DUNAWAY, BR, MASOUD ALIMOHAMMADI, JONAS HERTNER, URSULA GOODENOUGH, GREGORY HASTINGS, DAVID PINSOF, SEAN NELSON, MIKE LAVIGNE, JOS KNECHT, ERIK ENGMAN, AND LUCY! A SPECIAL THANKS TO MY PRODUCERS, YZAR WEHBE, JIM FRANK, ŁUKASZ STAFINIAK, TOM VANEGDOM, BERNARD HUGUENEY, CURTIS DIXON, BENEDIKT MUELLER, THOMAS TRUMBLE, KATHRINE AND PATRICK TOBIN, JONCARLO MONTENEGRO, AL NICK ORTIZ, AND NICK GOLDEN! AND TO MY EXECUTIVE PRODUCERS, MATTHEW LAVENDER, SERGIU CODREANU, BOGDAN KANIVETS, AND ROSEY!

Newscast brings you daily analysis of the latest news stories from the BBC. Today, we look at what's next for Ofsted. This follows an inquest into the death of head teacher Ruth Perry which ruled that Ofsted contributed to her death. The BBC's education editor Branwen Jeffreys, professor of Sociology of Education at UCL Institute of Education, Alice Bradbury, and executive principal of Passmores cooperative, Vic Goddard, join Adam to discuss the future of the schools regulator. And the sports minister of Saudi Arabia has denied accusations of sportswashing after his country won the right the host the 2034 World Cup. The Athletic's senior football news reporter Matt Slater breaks down why Saudi Arabia are investing in sport. You can join our Newscast online community here: https://tinyurl.com/newscastcommunityhere Today's Newscast was presented by Adam Fleming. It was made by Jack Maclaren with Joe Wilkinson and Natasa Simovic. The technical producer was Matt Hewitt. The senior news editors are Jonathan Aspinwall and Sam Bonham.

Today we air the next episode of Flux. This episode was created by Bhavani Kunjulakshmi, a recent graduate of the UCL Institute of Education and staff writer at Feminism in India. Bhavani's episode explores the meaning of colonization and decolonization in international development and education. We might think we know what colonization is. The history. The actors involved. The exploitation. But what does it feel like? And then what would it mean to decolonize? And what would that feel like? Bhavani explores these questions. freshedpodcast.com/flux-kunjulakshmi -- This episode was created, written, produced and edited by Bhavani Kunjulakshmi. Johannah Fahey was the executive producer. Brett Lashua and Will Brehm were the producers. Fred Brehm read the quote by Noah Chomsky and Fran Vavrus read the quote by Martha Nussbaum. Music was composed by M.C Couper The bell hooks' clip was a part of ‘A Public Dialogue between bell hooks & Laverne Cox hosted by Eugene Lang College of Liberal Arts' (Creative commons) The clip of Amartya Sen was a part of ‘Equality and growth – an interview with Amartya Sen' (Creative commons) Quote by Noam Chomsky about Kerala was from Pedagogy of the Oppressed: Noam Chomsky, Howard Gardner, and Bruno della Chiesa Askwith Forum (Creative commons) Quotes by Martha Nussbaum was from “Creating Capabilities: The Human Development Approach” (Creative commons) Music: The Spirituals Project – Sankofa – Oh Freedom (Creative commons) -- Learn more about Flux: freshedpodcast.com/flux/about/ Twitter: @FreshEdpodcast Facebook: FreshEd Email: info@freshedpodcast.com Support FreshEd: www.freshedpodcast.com/donate

Far away and not enough, those are criticisms of the government's latest net zero initiative – a plan to reduce emissions . We ask Jim Watson Professor of Energy Policy and Director of the UCL Institute for Sustainable Resources for his assessment. And there's money to be made from private health testing, the growth of Covid testing has been followed by an upsurge in private screening for cancer in particular, but how useful is it really? BBC Health correspondent Matthew Hill takes a look. Every cell in out body carries an electrical charge. In her new book, We Are Electric: The New Science of Our Body's Electrome, Sally Adee discusses how this facet might be harnessed for the detection of illnesses, medical treatments and whether it will allow us to develop hidden powers. The World Wood Web is a concept showing how trees communicate with each other through an underground fungal network. The idea was first proposed by Suzanne Simard, Now professor of Forest Ecology at the University of British Columbia, who tells us how she came up with the concept and about her work on the hidden relationships of trees.

What do the internet and COVID vaccines have in common? Neither would be possible without the work of DARPA, a mission-focused federal agency responsible for funding research and development. Professor Mariana Mazzucato explains that our economy would be better off if more government agencies adopted DARPA's mission-oriented approach. This episode was originally released in May 2021. You can find the show notes and transcript for that episode here. Mariana Mazzucato is a Professor in the Economics of Innovation and Public Value at University College London, where she is Founding Director of the UCL Institute for Innovation and Public Purpose. She is the author of three highly-acclaimed books: The Entrepreneurial State, The Value of Everything, and Mission Economy. Twitter: @MazzucatoM Mission Economy: https://marianamazzucato.com/books/mission-economy  It's 2023. Here's how we fixed the global economy: https://time.com/collection/great-reset/5900739/fix-economy-by-2023 DARPA's early investment in COVID-19 antibody identification producing timely results: https://www.darpa.mil/news-events/2020-11-10 Website: https://pitchforkeconomics.com Twitter: @PitchforkEcon Instagram: @pitchforkeconomics Nick's twitter: @NickHanauer